Schedule 13D ownership disclosure
PEREGRINE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 713661304
Event date: 2017-02-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 17,565,843
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-013538
- Form type
- SC 13D
- Filer
- Avid Bioservices, Inc.
- CIK
- CIK 704562
- Filed
- Mar 02, 2017
- Reporting period
- Feb 21, 2017
- Description
- Schedule 13D beneficial ownership